236 related articles for article (PubMed ID: 15252850)
1. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.
Saito R; Mizuno M; Nakahara N; Tsuno T; Kumabe T; Yoshimoto T; Yoshida J
Int J Cancer; 2004 Sep; 111(5):777-82. PubMed ID: 15252850
[TBL] [Abstract][Full Text] [Related]
2. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
Yamanaka R; Zullo SA; Tanaka R; Blaese M; Xanthopoulos KG
J Neurosurg; 2001 Mar; 94(3):474-81. PubMed ID: 11235953
[TBL] [Abstract][Full Text] [Related]
5. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma.
Jiang XB; Lu XL; Hu P; Liu RE
Vaccine; 2009 Oct; 27(44):6210-6. PubMed ID: 19699331
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
[TBL] [Abstract][Full Text] [Related]
7. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas.
Ni HT; Spellman SR; Jean WC; Hall WA; Low WC
J Neurooncol; 2001 Jan; 51(1):1-9. PubMed ID: 11349874
[TBL] [Abstract][Full Text] [Related]
8. Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA.
Yamanaka R; Yajima N; Tsuchiya N; Honma J; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG
J Neurosurg; 2002 Nov; 97(5):1184-90. PubMed ID: 12450042
[TBL] [Abstract][Full Text] [Related]
9. Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.
Xu M; Yao Y; Hua W; Wu Z; Zhong P; Mao Y; Zhou L; Luo F; Chu Y
J Neurooncol; 2014 Feb; 116(3):497-504. PubMed ID: 24398615
[TBL] [Abstract][Full Text] [Related]
10. Vaccine therapy with dendritic cells transfected with Il13ra2 mRNA for glioma in mice.
Saka M; Amano T; Kajiwara K; Yoshikawa K; Ideguchi M; Nomura S; Fujisawa H; Kato S; Fujii M; Ueno K; Hinoda Y; Suzuki M
J Neurosurg; 2010 Aug; 113(2):270-9. PubMed ID: 19895199
[TBL] [Abstract][Full Text] [Related]
11. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
Grauer OM; Sutmuller RP; van Maren W; Jacobs JF; Bennink E; Toonen LW; Nierkens S; Adema GJ
Int J Cancer; 2008 Apr; 122(8):1794-802. PubMed ID: 18076066
[TBL] [Abstract][Full Text] [Related]
12. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
Xu G; Guo Y; Seng Z; Cui G; Qu J
Oncol Rep; 2015 Oct; 34(4):1915-22. PubMed ID: 26252165
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
Yoshino A; Tashiro S; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Sano E; Tsumoto K
Int J Oncol; 2011 Sep; 39(3):529-42. PubMed ID: 21805051
[TBL] [Abstract][Full Text] [Related]
15. Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.
Nakahara N; Pollack IF; Storkus WJ; Wakabayashi T; Yoshida J; Okada H
Cancer Gene Ther; 2003 Jul; 10(7):549-58. PubMed ID: 12833135
[TBL] [Abstract][Full Text] [Related]
16. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.
Natsume A; Tsujimura K; Mizuno M; Takahashi T; Yoshida J
J Neurooncol; 2000 Apr; 47(2):117-24. PubMed ID: 10982152
[TBL] [Abstract][Full Text] [Related]
17. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
[TBL] [Abstract][Full Text] [Related]
18. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model.
Jouanneau E; Poujol D; Gulia S; Le Mercier I; Blay JY; Belin MF; Puisieux I
Cancer Immunol Immunother; 2006 Mar; 55(3):254-67. PubMed ID: 16133115
[TBL] [Abstract][Full Text] [Related]
20. Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.
Kjaergaard J; Wang LX; Kuriyama H; Shu S; Plautz GE
J Neurosurg; 2005 Jul; 103(1):156-64. PubMed ID: 16121986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
